ROGER CRYSTAL
CIK 1656633 · Chief Executive Officer · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
23
Lifetime Open-Market Net
-$2.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 19,623 | $15.00 | $294.3K | $0 | 4 | 2025-06-16 |
| OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Chief Executive Officer | 6,667 | $20.65 | $137.7K | -$2.05M | 18 | 2023-03-03 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-10 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Sell (S) | −10,847 | -$186.7K | EDGAR |
| 2018-10-04 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Mixed | +10,847 | -$121.7K | EDGAR |
| 2017-01-19 | — | Buy (P) | +3,475 | $24.3K |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.